229 related articles for article (PubMed ID: 17199453)
1. Adherence to federal guidelines for reporting of sex and race/ethnicity in clinical trials.
Geller SE; Adams MG; Carnes M
J Womens Health (Larchmt); 2006 Dec; 15(10):1123-31. PubMed ID: 17199453
[TBL] [Abstract][Full Text] [Related]
2. Inclusion, analysis, and reporting of sex and race/ethnicity in clinical trials: have we made progress?
Geller SE; Koch A; Pellettieri B; Carnes M
J Womens Health (Larchmt); 2011 Mar; 20(3):315-20. PubMed ID: 21351877
[TBL] [Abstract][Full Text] [Related]
3. Sex and race/ethnicity reporting in clinical trials: a necessity, not an option.
Blauwet LA
J Womens Health (Larchmt); 2011 Mar; 20(3):313-4. PubMed ID: 21351875
[No Abstract] [Full Text] [Related]
4. Women subjects in NIH-funded clinical research literature: lack of progress in both representation and analysis by sex.
Vidaver RM; Lafleur B; Tong C; Bradshaw R; Marts SA
J Womens Health Gend Based Med; 2000 Jun; 9(5):495-504. PubMed ID: 10883941
[TBL] [Abstract][Full Text] [Related]
5. The More Things Change, the More They Stay the Same: A Study to Evaluate Compliance With Inclusion and Assessment of Women and Minorities in Randomized Controlled Trials.
Geller SE; Koch AR; Roesch P; Filut A; Hallgren E; Carnes M
Acad Med; 2018 Apr; 93(4):630-635. PubMed ID: 29053489
[TBL] [Abstract][Full Text] [Related]
6. Why should we include women and minorities in randomized controlled trials?
Weijer C; Crouch RA
J Clin Ethics; 1999; 10(2):100-6. PubMed ID: 10633280
[No Abstract] [Full Text] [Related]
7. Underreporting of Gender and Race/Ethnicity Differences in NIH-Funded Dementia Caregiver Support Interventions.
Gilmore-Bykovskyi A; Johnson R; Walljasper L; Block L; Werner N
Am J Alzheimers Dis Other Demen; 2018 May; 33(3):145-152. PubMed ID: 29281895
[TBL] [Abstract][Full Text] [Related]
8. Moving toward true inclusion of racial/ethnic minorities in federally funded studies. A key step for achieving respiratory health equality in the United States.
Burchard EG; Oh SS; Foreman MG; Celedón JC
Am J Respir Crit Care Med; 2015 Mar; 191(5):514-21. PubMed ID: 25584658
[TBL] [Abstract][Full Text] [Related]
9. Twenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trials.
Chen MS; Lara PN; Dang JH; Paterniti DA; Kelly K
Cancer; 2014 Apr; 120 Suppl 7(0 7):1091-6. PubMed ID: 24643646
[TBL] [Abstract][Full Text] [Related]
10. The inclusion of minority groups in clinical trials: problems of under representation and under reporting of data.
Rochon PA; Mashari A; Cohen A; Misra A; Laxer D; Streiner DL; Clark JP; Dergal JM; Gold J
Account Res; 2004; 11(3-4):215-23. PubMed ID: 15812967
[TBL] [Abstract][Full Text] [Related]
11. Lack of diversity in orthopaedic trials conducted in the United States.
Somerson JS; Bhandari M; Vaughan CT; Smith CS; Zelle BA
J Bone Joint Surg Am; 2014 Apr; 96(7):e56. PubMed ID: 24695933
[TBL] [Abstract][Full Text] [Related]
12. Enrollment of racial/ethnic minorities and women with HIV in clinical research studies of HIV medicines.
Sullivan PS; McNaghten AD; Begley E; Hutchinson A; Cargill VA
J Natl Med Assoc; 2007 Mar; 99(3):242-50. PubMed ID: 17393948
[TBL] [Abstract][Full Text] [Related]
13. Hispanic research: implications of the National Institutes of Health guidelines on inclusion of women and minorities in clinical research.
Caban CE
J Natl Cancer Inst Monogr; 1995; (18):165-9. PubMed ID: 8562217
[TBL] [Abstract][Full Text] [Related]
14. Reporting and Representation of Participant Race and Ethnicity in National Institutes of Health-Funded Pediatric Clinical Trials.
Lee LK; Narang C; Rees CA; Thiagarajan RR; Melvin P; Ward V; Bourgeois FT
JAMA Netw Open; 2023 Aug; 6(8):e2331316. PubMed ID: 37647067
[TBL] [Abstract][Full Text] [Related]
15. Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute.
Harris DJ; Douglas PS
N Engl J Med; 2000 Aug; 343(7):475-80. PubMed ID: 10944565
[TBL] [Abstract][Full Text] [Related]
16. The new NIH and FDA medical research policies: targeting gender, promoting justice.
Baird KL
J Health Polit Policy Law; 1999 Jun; 24(3):531-65. PubMed ID: 10386326
[TBL] [Abstract][Full Text] [Related]
17. Minority Representation in Migraine Treatment Trials.
Robbins NM; Bernat JL
Headache; 2017 Mar; 57(3):525-533. PubMed ID: 28127754
[TBL] [Abstract][Full Text] [Related]
18. Reporting and representation of race/ethnicity in published randomized trials.
Berger JS; Melloni C; Wang TY; Dolor RJ; Frazier CG; Samad Z; Peterson ED; Mark DB; Newby LK
Am Heart J; 2009 Nov; 158(5):742-7. PubMed ID: 19853691
[TBL] [Abstract][Full Text] [Related]
19. Representation of women in randomized clinical trials of cardiovascular disease prevention.
Melloni C; Berger JS; Wang TY; Gunes F; Stebbins A; Pieper KS; Dolor RJ; Douglas PS; Mark DB; Newby LK
Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):135-42. PubMed ID: 20160159
[TBL] [Abstract][Full Text] [Related]
20. Inclusion and reporting of sex, gender, and race/ethnicity in randomized controlled trials of nonpharmacological treatments for alcohol use disorder: A meta-epidemiologic review.
Schick MR; Nalven T; Lynch-Gadaleta B; Hostetler KL; Crawford MC; Spillane NS
Alcohol Clin Exp Res; 2022 Jul; 46(7):1154-1165. PubMed ID: 35904527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
